Rheumatoid Arthritis

Recommendations and Guidelines

EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2022 update                             (Ann Rheum Dis. 2023 Jan;82(1):3-18. doi: 10.1136/ard-2022-223356. Epub 2022 Nov 10. )                                                                                                                                      http://ard.bmj.com/content/82/1/3

EULAR points to considerer for the management of difficult-to-treat rheumatoid arthritisr                                                                                                                                                 (Ann RheumDis.2022 Jan;81(1):20-33.doi: 10.1136/annrheumdis-2021-220973.)                                                                                                                                      http://ard.bmj.com/content/81/1/20

EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2016 update
(Ann Rheum Dis. 2017 Jun;76(6):960-977. doi: 10.1136/annrheumdis-2016-210715. Epub 2017 Mar 6.)
http://ard.bmj.com/content/76/6/960.long

EULAR Recommendations for cardiovascular risk management in patients with rheumatoid arthritis and other inflammatory joint diseases - 2014/15 Update
(Ann Rheum Dis doi:10.1136/annrheumdis-2016-209775)
http://ard.bmj.com/content/early/2016/10/03/annrheumdis-2016-209775?papetoc

2015 American College of Rheumatology Guideline for the Treatment of Rheumatoid Arthritis
(Arthritis Rheumatol. 2016 Jan;68(1):1-26)
http://onlinelibrary.wiley.com/doi/10.1002/art.39480/full

NICE Clinical Guideline for Rheumatoid arthritis management
Published date: February 2009 Last updated: December 2015
http://www.nice.org.uk/nicemedia/pdf/CG79NICEGuideline.pdf

EULAR recommendations for the use of imaging of the joints in the clinical management of rheumatoid arthritis
Ann Rheum Dis doi:10.1136/annrheumdis-2012-203158
http://ard.bmj.com/content/early/2013/03/20/annrheumdis-2012-203158.full

Treating rheumatoid arthritis to target: recommendations of an international task force
(Ann Rheum Dis 2010;69:631-637)
http://ard.bmj.com/content/69/4/631.full

Criteria and Outcome Measures

Classification criteria

2010 Rheumatoid arthritis classification criteria: an American College of Rheumatology/European League Against Rheumatism collaborative initiative
(Ann Rheum Dis 2010;69:1580-1588)
http://ard.bmj.com/content/69/9/1580.long

Remission criteria

American College of Rheumatology/EULAR Remission Criteria in Rheumatoid Arthritis: 2022 revision
(Ann Rheum Dis 2023 Jan;82(1):74-80.doi: 10.1136/ard-2022-223413
http://ard.bmj.com/content/82/1/74.long

American College of Rheumatology/European League Against Rheumatism Provisional Definition of Remission in Rheumatoid Arthritis for Clinical Trials
(Ann Rheum Dis 2011;70:404-413)
http://ard.bmj.com/content/70/3/404.full

Remission in rheumatoid arthritis: agreement of the disease activity score (DAS28) with the ARA preliminary remission criteria
(Rheumatology (Oxford). 2004 Oct;43(10):1252-5.)
http://rheumatology.oxfordjournals.org/content/43/10/1252.full

Disease Scores, scales and questionnaires

See also the Disease calculators, EULAR outcome measures for a complete overview of disease scores in rheumatoid diseases and links to online calculators.

Disease Activity Score 28 (DAS28) and RADAI
Arthritis Rheum 2003;49 Suppl:S214–24.
http://onlinelibrary.wiley.com/doi/10.1002/art.11407/full

Clinical Disease Activity Index (CDAI)
(Arthritis Res Ther 2005;7:R796–806.)
http://arthritis-research.biomedcentral.com/articles/10.1186/ar1740
http://www.clinexprheumatol.org/article.asp?a=2694

Simplified Disease Activity Index (SDAI)
(Rheumatology (Oxford) 2003;42:244–57.)
http://rheumatology.oxfordjournals.org/content/42/2/244.full
http://www.clinexprheumatol.org/article.asp?a=2694..

Routine Assessment of Patient Index Data 3 (RAPID-3)
(Best Pract Res Clin Rheumatol. 2007 Aug;21(4):755-87.)
http://onlinelibrary.wiley.com/doi/10.1002/acr.20481/abstract;jsessionid=FEF9444D8A5D9CA4C78105FB32D49F60.f04t01

HAQ
http://hqlo.biomedcentral.com/articles/10.1186/1477-7525-1-20

SF-36 questionnaire
Original manuscript: https://www.jstor.org/stable/3765916?seq=1#page_scan_tab_contents
SF-36 in RA: https://academic.oup.com/rheumatology/article/36/4/463/1783344/Use-of-the-short-form-36-SF36-for-health-status

Imaging Tools

An introduction to the EULAR-OMERACT rheumatoid arthritis MRI reference image atlas
(Ann Rheum Dis 2005;64:i3–i7)
http://ard.bmj.com/content/64/suppl_1/i3.full.pdf

The EULAR–OMERACT rheumatoid arthritis MRI reference image atlas: the metacarpophalangeal joints
(Ann Rheum Dis 2005;64:i11-i21)
http://ard.bmj.com/content/64/suppl_1/i11.long

The EULAR–OMERACT rheumatoid arthritis MRI reference image atlas: the wrist joint.
(Ann Rheum Dis 2005;64:i23-i47)
http://ard.bmj.com/content/64/suppl_1/i23.full

Miscellaneous

Cytokine Signalling Forum
The CSF (www.cytokinesignalling.com) is a free online educational resource for health care professionals that focuses on the impact of cytokine signalling therapies in rheumatoid arthritis. They offer free publication reviews, slide resources and the ability to request a virtual lecture from one of our world leading steering committee.
http://www.cytokinesignalling.com

Outcome Measures in Rheumatology (OMERACT)
OMERACT is an informal international network of working groups and gatherings interested in outcome measurement across the spectrum of rheumatology intervention studies.
http://www.omeract.org